• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适应性无缝试验中亚组选择后的估计

Estimation after subpopulation selection in adaptive seamless trials.

作者信息

Kimani Peter K, Todd Susan, Stallard Nigel

机构信息

Warwick Medical School, The University of Warwick, Coventry, CV4 7AL, U.K.

Department of Mathematics and Statistics, The University of Reading, RG6 6AX, Reading, U.K.

出版信息

Stat Med. 2015 Aug 15;34(18):2581-601. doi: 10.1002/sim.6506. Epub 2015 Apr 22.

DOI:10.1002/sim.6506
PMID:25903293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4973856/
Abstract

During the development of new therapies, it is not uncommon to test whether a new treatment works better than the existing treatment for all patients who suffer from a condition (full population) or for a subset of the full population (subpopulation). One approach that may be used for this objective is to have two separate trials, where in the first trial, data are collected to determine if the new treatment benefits the full population or the subpopulation. The second trial is a confirmatory trial to test the new treatment in the population selected in the first trial. In this paper, we consider the more efficient two-stage adaptive seamless designs (ASDs), where in stage 1, data are collected to select the population to test in stage 2. In stage 2, additional data are collected to perform confirmatory analysis for the selected population. Unlike the approach that uses two separate trials, for ASDs, stage 1 data are also used in the confirmatory analysis. Although ASDs are efficient, using stage 1 data both for selection and confirmatory analysis introduces selection bias and consequently statistical challenges in making inference. We will focus on point estimation for such trials. In this paper, we describe the extent of bias for estimators that ignore multiple hypotheses and selecting the population that is most likely to give positive trial results based on observed stage 1 data. We then derive conditionally unbiased estimators and examine their mean squared errors for different scenarios.

摘要

在新疗法的研发过程中,测试一种新治疗方法是否比现有治疗方法对所有患有某种疾病的患者(总体人群)或总体人群的一个子集(亚组人群)效果更好,这种情况并不罕见。可用于此目的的一种方法是进行两项独立试验,在第一项试验中,收集数据以确定新治疗方法是否对总体人群或亚组人群有益。第二项试验是一项确证性试验,用于在第一项试验中选定的人群中测试新治疗方法。在本文中,我们考虑更有效的两阶段自适应无缝设计(ASD),其中在第1阶段,收集数据以选择在第2阶段进行测试的人群。在第2阶段,收集额外数据以对选定人群进行确证性分析。与使用两项独立试验的方法不同,对于ASD,第1阶段的数据也用于确证性分析。尽管ASD很有效,但将第1阶段的数据同时用于选择和确证性分析会引入选择偏差,从而在进行推断时带来统计挑战。我们将专注于此类试验的点估计。在本文中,我们描述了忽略多个假设并根据观察到的第1阶段数据选择最有可能给出阳性试验结果的人群时估计量的偏差程度。然后我们推导条件无偏估计量,并检查它们在不同情况下的均方误差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/01dad43ff8f6/SIM-34-2581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/7f9126502dc1/SIM-34-2581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/f3326e134df3/SIM-34-2581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/01dad43ff8f6/SIM-34-2581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/7f9126502dc1/SIM-34-2581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/f3326e134df3/SIM-34-2581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc9/4973856/01dad43ff8f6/SIM-34-2581-g003.jpg

相似文献

1
Estimation after subpopulation selection in adaptive seamless trials.适应性无缝试验中亚组选择后的估计
Stat Med. 2015 Aug 15;34(18):2581-601. doi: 10.1002/sim.6506. Epub 2015 Apr 22.
2
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.有条件无偏估计在具有无效性提前停止的 II/III 期临床试验中。
Stat Med. 2013 Jul 30;32(17):2893-910. doi: 10.1002/sim.5757. Epub 2013 Feb 15.
3
Adjusting for treatment selection in phase II/III clinical trials with time to event data.调整具有生存时间数据的 II/III 期临床试验中的治疗选择。
Stat Med. 2023 Jan 30;42(2):146-163. doi: 10.1002/sim.9606. Epub 2022 Nov 23.
4
Point estimation following two-stage adaptive threshold enrichment clinical trials.两阶段自适应阈值富集临床试验后的点估计。
Stat Med. 2018 Sep 30;37(22):3179-3196. doi: 10.1002/sim.7831. Epub 2018 May 31.
5
Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.在具有不等治疗效果方差和假设驱动选择规则的无缝II/III期试验中的无偏估计。
Stat Med. 2016 Sep 30;35(22):3907-22. doi: 10.1002/sim.6974. Epub 2016 Apr 21.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.在中期进行假设选择的验证性无缝II/III期临床试验:一般概念
Biom J. 2006 Aug;48(4):623-34. doi: 10.1002/bimj.200510232.
8
Statistical Inference for a Two-Stage Adaptive Seamless Design Using Different Binary Endpoints.使用不同二元终点的两阶段自适应无缝设计的统计推断
Stat Med. 2025 Mar 15;44(6):e70003. doi: 10.1002/sim.70003.
9
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.一种用于肿瘤学试验的适应性无缝II/III期设计,该设计使用相关生存终点进行亚组选择。
Pharm Stat. 2011 Jul-Aug;10(4):347-56. doi: 10.1002/pst.472. Epub 2010 Dec 8.
10
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.具有事件发生时间数据和生物标志物驱动的亚组选择的两阶段自适应设计中的点估计和区间估计。
Stat Med. 2020 Aug 30;39(19):2568-2586. doi: 10.1002/sim.8557. Epub 2020 May 3.

引用本文的文献

1
Latest Developments in "Adaptive Enrichment" Clinical Trial Designs in Oncology.肿瘤学中“适应性富集”临床试验设计的最新进展。
Ther Innov Regul Sci. 2024 Nov;58(6):1201-1213. doi: 10.1007/s43441-024-00698-3. Epub 2024 Sep 13.
2
A Bayesian decision-theoretic design for simultaneous biomarker-based subgroup selection and efficacy evaluation.一种基于贝叶斯决策理论的设计,用于同时进行基于生物标志物的亚组选择和疗效评估。
Stat Biopharm Res. 2022;14(4):568-579. doi: 10.1080/19466315.2021.1873843. Epub 2021 Feb 9.
3
Point estimation for adaptive trial designs I: A methodological review.

本文引用的文献

1
Simultaneous confidence intervals that are compatible with closed testing in adaptive designs.与适应性设计中的封闭检验兼容的同时置信区间。
Biometrika. 2013 Dec 1;100(4):985-996. doi: 10.1093/biomet/ast035.
2
Adaptive designs for confirmatory clinical trials with subgroup selection.用于带有亚组选择的确证性临床试验的适应性设计
J Biopharm Stat. 2014;24(1):168-87. doi: 10.1080/10543406.2013.857238.
3
A comparison of methods for constructing confidence intervals after phase II/III clinical trials.II/III期临床试验后构建置信区间方法的比较
自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
4
Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs.两阶段自适应富集和伞式设计中的亚组选择优化。
Stat Med. 2021 May 30;40(12):2939-2956. doi: 10.1002/sim.8949. Epub 2021 Mar 29.
5
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers.基于基线生物标志物对反应和生存时间的自适应回归的贝叶斯分组序贯富集设计。
Biometrics. 2022 Mar;78(1):60-71. doi: 10.1111/biom.13421. Epub 2021 Jan 27.
6
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.具有事件发生时间数据和生物标志物驱动的亚组选择的两阶段自适应设计中的点估计和区间估计。
Stat Med. 2020 Aug 30;39(19):2568-2586. doi: 10.1002/sim.8557. Epub 2020 May 3.
7
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R.自适应无缝临床试验,使用早期结果进行治疗或亚组选择:方法、模拟模型及其在 R 中的实现。
Biom J. 2020 Sep;62(5):1264-1283. doi: 10.1002/bimj.201900020. Epub 2020 Mar 2.
8
Using simulation studies to evaluate statistical methods.运用模拟研究评估统计方法。
Stat Med. 2019 May 20;38(11):2074-2102. doi: 10.1002/sim.8086. Epub 2019 Jan 16.
9
Design and estimation in clinical trials with subpopulation selection.亚组人群选择的临床试验设计与估计。
Stat Med. 2018 Dec 20;37(29):4335-4352. doi: 10.1002/sim.7925. Epub 2018 Aug 7.
10
Point estimation following two-stage adaptive threshold enrichment clinical trials.两阶段自适应阈值富集临床试验后的点估计。
Stat Med. 2018 Sep 30;37(22):3179-3196. doi: 10.1002/sim.7831. Epub 2018 May 31.
Biom J. 2014 Jan;56(1):107-28. doi: 10.1002/bimj.201300036. Epub 2013 Oct 31.
4
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.有条件无偏估计在具有无效性提前停止的 II/III 期临床试验中。
Stat Med. 2013 Jul 30;32(17):2893-910. doi: 10.1002/sim.5757. Epub 2013 Feb 15.
5
A conditional error function approach for subgroup selection in adaptive clinical trials.自适应临床试验中亚组选择的条件误差函数方法。
Stat Med. 2012 Dec 30;31(30):4309-20. doi: 10.1002/sim.5541. Epub 2012 Aug 3.
6
Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection.两阶段自适应设计中基于中期治疗选择的收缩估计。
Stat Med. 2013 May 10;32(10):1677-90. doi: 10.1002/sim.5463. Epub 2012 Jun 29.
7
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.实用指南:使用贝叶斯方法的适应性无缝二期/三期临床试验
Stat Med. 2012 Aug 30;31(19):2068-85. doi: 10.1002/sim.5326. Epub 2012 Mar 22.
8
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.一种用于肿瘤学试验的适应性无缝II/III期设计,该设计使用相关生存终点进行亚组选择。
Pharm Stat. 2011 Jul-Aug;10(4):347-56. doi: 10.1002/pst.472. Epub 2010 Dec 8.
9
Interval estimation in two-stage, drop-the-losers clinical trials with flexible treatment selection.两阶段、有剔除失败者的临床试验中灵活治疗选择的区间估计。
Stat Med. 2011 Oct 15;30(23):2804-14. doi: 10.1002/sim.4308. Epub 2011 Aug 8.
10
Efficacy of vagus nerve stimulation for refractory epilepsy among patient subgroups: a re-analysis using the Engel classification.迷走神经刺激治疗难治性癫痫患者亚组的疗效:基于恩格尔分类的再分析。
Seizure. 2011 May;20(4):331-5. doi: 10.1016/j.seizure.2011.01.002. Epub 2011 Jan 26.